Staff at the Connecticut Hospice in Branford (the country’s first hospice center) stated they are hoping to advance pain management while cutting down opioid use in treatment. They plan to study how medical cannabis can help the fated patients.
Doctor Wen-Jen Hwu, professor of medical oncology at the MD Anderson Cancer Center, stated that the target of this revolutionary medical cannabis study will be to ease end of life patients’ discomfort and improve their quality of life. They also want to decrease nausea while improving patients’ appetites and well-being.
Hwu stated, “Connecticut Hospice has the vision of trying to better fulfill their mission in palliative care and symptom control to improve the quality of life of those with limited time but it’s still very important. Everybody deserves to die with dignity.”
The first federally approved medical cannabis study was announced by CT. Governor Daniel Malloy and U.S. Senator Richard Blumenthal at the news conference. Blumenthal stated, “It’s about pain management at the end of life or during medical procedures, and that can transform the quality of life for people undergoing medical procedures no matter how serious or at what stage and it can reduce the costs of health care.”
There are 66 patients that will help determine the safety and benefits of using medical cannabis for pain management. Most of these patients need opioids. Their conditions usually worsen and almost always see an increase in addictive painkillers. Those participating will receive the medical cannabis in the form of a pill.
Governor Malloy also announced that a state approved study will be performed at Saint Francis Hospital in Hartford. This study will be related to the treatment of traumatic injuries. They would like to see how well the cannabis pill replaces addictive painkillers.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
